Phase II study of 3-hour infusion of paclitaxel in patients with previously untreated non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Furuse, K
Naka, N
Ariyoshi, Y
Ikegami, H
Fukuoka, M
Yamakido, M
机构：
[1] NATL SANAT KINKI CENT HOSP,DEPT INTERNAL MED,OSAKA,JAPAN
[2] AICHI CANC CTR HOSP,DEPT CARDIOPULM DIS,AICHI,JAPAN
[3] OSAKA PREFECTURAL MED CTR ADULT DIS,DEPT INTERNAL MED 4,OSAKA,JAPAN
[4] HIROSHIMA UNIV,DEPT INTERNAL MED 2,HIROSHIMA,JAPAN
[5] OSAKA CITY GEN HOSP,DEPT PULM MED,OSAKA,JAPAN
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1072 / 1072
页数：1
相关论文
共 50 条
  • [31] Single-agent paclitaxel in advanced non-small cell lung cancer: Single-center phase II study using a 3-hour administration schedule
    Ranson, MR
    Jayson, G
    Perkins, S
    Anderson, H
    Thatcher, N
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 6 - 9
  • [32] Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer
    Ramalingam, S
    Belani, CP
    Day, R
    Zamboni, BA
    Jacobs, SA
    Jett, JR
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 247 - 251
  • [33] Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy
    Yoh, Kiyotaka
    Kubota, Kaoru
    Kakinuma, Ryutaro
    Ohmatsu, Hironobu
    Goto, Koichi
    Niho, Seiji
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    LUNG CANCER, 2007, 58 (01) : 73 - 79
  • [34] A phase II study of erlotinib (E) and bevacizumab (B) in patients (pts) with previously untreated stage IIIB/IV non-small cell lung cancer (NSCLC)
    Groen, H. J.
    Smit, E. F.
    Dingemans, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] A PHASE II STUDY OF S-1 FOR PREVIOUSLY UNTREATED ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Tomonaga, N.
    Ikeda, T.
    Tomonaga, M.
    Kinoshita, A.
    Fukuda, M.
    Kasai, T.
    Fukuda, M.
    Nakamura, Y.
    Oka, M.
    Kohno, S.
    RESPIROLOGY, 2012, 17 : 82 - 82
  • [36] A PHASE II STUDY OF S-1 FOR PREVIOUSLY UNTREATED ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Fukuda, M.
    Kasai, T.
    Fukuda, M.
    Nakamura, Y.
    Soejima, Y.
    Takatani, H.
    Nakatomi, K.
    Kinoshita, A.
    Oka, M.
    Kohno, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 156 - 157
  • [37] A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Kasai, Takashi
    Nakamura, Yoichi
    Fukuda, Minoru
    Kitazaki, Takeshi
    Nagashima, Seiji
    Takatani, Hiroshi
    Nakano, Hirofumi
    Nakatomi, Katsumi
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Tsukamoto, Kazuhiro
    Oka, Mikio
    Kohno, Shigeru
    CHEMOTHERAPY, 2015, 61 (02) : 93 - 98
  • [38] Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer
    Breathnach, OS
    Georgiadis, MS
    Schuler, BS
    Pizzella, P
    Llorens, V
    Kasturi, V
    Steinberg, SM
    O'Neil, K
    Takimoto, CH
    Johnson, BE
    CLINICAL CANCER RESEARCH, 2000, 6 (07) : 2670 - 2676
  • [39] Phase Ib/II study of DMXAA combined with carboplatin and paclitaxel in non-small cell lung cancer (NSCLC).
    McKeage, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 389S - 389S
  • [40] Phase II trial of weekly paclitaxel in previously untreated advanced non-small-cell lung cancer
    Yasuda, K
    Igishi, T
    Kawasaki, Y
    Yamamoto, M
    Kato, K
    Matsumoto, S
    Kotani, M
    Sako, T
    Shigeoka, Y
    Sugitani, A
    Histuda, Y
    Shimizu, E
    ONCOLOGY, 2003, 65 (03) : 224 - 228
12345